JENNIFER THERY: Open Payments
NPI 1730509159 · MARYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,728 in 185 payments from 20 companies in 2025. Trend: 2023 $12,500 · 2024 $19,446 · 2025 $35,728
Speaker / faculty: $27,780Food & beverage: $3,482Consulting: $2,530Travel & lodging: $1,936
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $19,350 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $14,039 |
| Janssen Pharmaceuticals, Inc | 15 | $420 |
| Otsuka America Pharmaceutical, Inc. | 12 | $286 |
| Supernus Pharmaceuticals, Inc. | 13 | $268 |
| ABBVIE INC. | 22 | $243 |
| Alkermes, Inc. | 18 | $204 |
| Axsome Therapeutics, Inc. | 8 | $200 |
| LivaNova USA, Inc. | 3 | $189 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
Products named: CAPLYTA, AUSTEDO XR, UZEDY, REXULTI, INVEGA SUSTENNA, Qelbree, VRAYLAR, ARISTADA.
Industry payments across IL — which companies pay providers there.
